These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 30280763)

  • 1. The down-regulation of long non-coding RNA LINC01088 is associated with the poor prognosis of epithelial ovarian cancer patients.
    Ai H; Xie W; Xiu AH; Li N; Zhang ST; Zhang YL; Xue XO
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5836-5841. PubMed ID: 30280763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo.
    Zeng S; Liu S; Feng J; Gao J; Xue F
    Cancer Biomark; 2019; 24(4):421-428. PubMed ID: 30909184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long Noncoding RNA LINC01554 as a Novel Biomarker for Diagnosis and Prognosis Prediction of Epithelial Ovarian Cancer.
    Luo T; Jiang Y; Yang J
    Dis Markers; 2021; 2021():1244612. PubMed ID: 34422133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CircHIPK3 is upregulated and predicts a poor prognosis in epithelial ovarian cancer.
    Liu N; Zhang J; Zhang LY; Wang L
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3713-3718. PubMed ID: 29949144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-532-5p is a prognostic marker and suppresses cells proliferation and invasion by targeting TWIST1 in epithelial ovarian cancer.
    Wei H; Tang QL; Zhang K; Sun JJ; Ding RF
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5842-5850. PubMed ID: 30280764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of lncRNA MNX1-AS1 is associated with poor clinical outcome in epithelial ovarian cancer.
    Li AH; Zhang HH
    Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5618-5623. PubMed ID: 29271994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA CPS1-IT1 is a positive prognostic factor and inhibits epithelial ovarian cancer tumorigenesis.
    Wang YS; Ma LN; Sun JX; Liu N; Wang H
    Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3169-3175. PubMed ID: 28770969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of lnc-MyD88 and its relationship with the prognosis of patients with epithelial ovarian cancer].
    Zhu Y; Huang JM; Zhang GN; Li JM; Huang J
    Zhonghua Fu Chan Ke Za Zhi; 2022 Feb; 57(2):117-124. PubMed ID: 35184472
    [No Abstract]   [Full Text] [Related]  

  • 9. CKS2 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in epithelial ovarian cancer.
    Xu JH; Wang Y; Xu D
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3225-3234. PubMed ID: 31081074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma.
    Zhang W; Niu C; He W; Hou T; Sun X; Xu L; Zhang Y
    Tumour Biol; 2016 May; 37(5):6239-54. PubMed ID: 26615423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of long noncoding RNA DLX6-AS1 defines good prognosis and inhibits proliferation and metastasis in human epithelial ovarian cancer cells via Notch signaling pathway.
    Zhao J; Liu HR
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3243-3252. PubMed ID: 31081076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of long non-coding RNA HOTAIR predicts poor patient prognosis and promotes tumor metastasis in epithelial ovarian cancer.
    Qiu JJ; Lin YY; Ye LC; Ding JX; Feng WW; Jin HY; Zhang Y; Li Q; Hua KQ
    Gynecol Oncol; 2014 Jul; 134(1):121-8. PubMed ID: 24662839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Significance of Increased Expression of Annexin A10 (ANXA10) in Serous Epithelial Ovarian Cancer.
    Wang J; Zhao S; Wang F; Wang J; Zhang Y
    Med Sci Monit; 2019 Jul; 25():5666-5673. PubMed ID: 31363077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of long noncoding RNA HMMR-AS1 in epithelial ovarian cancer: an independent prognostic factor.
    Chu ZP; Dai J; Jia LG; Li J; Zhang Y; Zhang ZY; Yan P
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8145-8150. PubMed ID: 30556852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of GPNMB predicts an unfavorable outcome of epithelial ovarian cancer.
    Ma RQ; Tang ZJ; Ye X; Cheng HY; Sun KK; Chang XH; Cui H
    Arch Gynecol Obstet; 2018 May; 297(5):1235-1244. PubMed ID: 29428978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LINC01088 inhibits tumorigenesis of ovarian epithelial cells by targeting miR-24-1-5p.
    Zhang W; Fei J; Yu S; Shen J; Zhu X; Sadhukhan A; Lu W; Zhou J
    Sci Rep; 2018 Feb; 8(1):2876. PubMed ID: 29440672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mir-595 is a significant indicator of poor patient prognosis in epithelial ovarian cancer.
    Zhou QH; Zhao YM; Jia LL; Zhang Y
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(19):4278-4282. PubMed ID: 29077170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and clinical significance of estrogen-regulated long non-coding RNAs in estrogen receptor α-positive ovarian cancer progression.
    Qiu JJ; Ye LC; Ding JX; Feng WW; Jin HY; Zhang Y; Li Q; Hua KQ
    Oncol Rep; 2014 Apr; 31(4):1613-22. PubMed ID: 24481591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
    Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
    J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis.
    Huang S; Qing C; Huang Z; Zhu Y
    Diagn Pathol; 2016 Jun; 11(1):49. PubMed ID: 27283598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.